Find and Pitch Jounalists, Get Your Story Covered

Tags: biotech biotechnology Congress drug development Drug prices

	Profile	Recent Articles on Subject
1	Allison DeAngelis STAT News Reporter at STAT. Formerly Insider, BBJ. biopharmastartupsventure capital	STAT+: Novo Nordisk sets sights on new type of oral obesity drug - 15 days ago STAT+: Novo Nordisk enlists two Flagship biotechs to develop obesity, MASH drugs - over 1 year ago
2	Elaine Chen STAT News Reporter at STATnews. Formerly at Business Insider. Chicago, Illinois journalism	STAT+: Novo Nordisk sets sights on new type of oral obesity drug - 15 days ago STAT+: High-dose Wegovy leads to substantial weight loss in trial, but falls short of Zepbound - 3 months ago More than 1 billion people have obesity, including 159 million young people, study estimates - about 1 year ago STAT+: Liver disease MASH is next target for obesity drugs in development - about 1 year ago STAT+: What comes after Wegovy? The quest to eradicate obesity - over 1 year ago Obesity drugs’ next tests, and rising threats: 3 chronic disease stories to watch - over 1 year ago STAT+: Pfizer to halt development of its twice-daily oral obesity drug, following disappointing trial - over 1 year ago AMA urges coverage of obesity treatments as payers balk at costs - over 1 year ago STAT+: Our expensive obesity drugs are worth it, Novo Nordisk and Eli Lilly argue in raft of studies - over 1 year ago
3	Elie Dolgin Nature Science journalist. Writes for eliedolgin.com. Somerville, Massachusetts science journalism	Dozens of new obesity drugs are coming: these are the ones to watch - about 2 months ago
4	Flora Graham Nature Writes Nature Briefing. Tweets own. On B’sky. London, United Kingdom science	Daily briefing: New obesity definition sidelines BMI to focus on health - 3 months ago Daily briefing: What causes obesity? Contentious topic gets an authoritative analysis - 7 months ago
5	Kristen Monaco MedPage Today	One Racial Group Is Less Likely to Go Through With Bariatric Surgery - 3 months ago 75% of Adults Overweight or Obese; Global Diabetes Tx Lacking; Hidden Bone Data? - 5 months ago Early-Stage GLP-1 Win in Obesity; An Argument for BMI's Value; Insulin Supply Issues - 9 months ago Adolescent Obesity Tied to Parents' BMI at the Same Age - 10 months ago USPSTF Recommends Behavioral Interventions for Kids With High BMI - 10 months ago Surgery May Be More Cost-Effective Than Wegovy in Adults With a BMI 35+ - 12 months ago Amy Schumer's Cushing's Dx; One Billion People With Obesity; Vitamin D for T1D - about 1 year ago Lower Insulin Costs; Older Folks Want Obesity Meds Covered; Global Ozempic Woes - over 1 year ago Phase II Wins, Losses for Obesity Drugs; More Positive Veozah Data; Walking Off T2D - over 1 year ago Year in Review: Obesity - over 1 year ago Mounjaro vs Ozempic for Obesity; New Microwave Ablation System; GAHT Erythrocytosis - over 1 year ago Over One-Third of Adults in 22 States Have Obesity, CDC Says - over 1 year ago
6	Marissa Plescia MedCity News Reporter at MedCity News. reportingjournalism	Form Health Unveils New Program to Prevent the Transition from Overweight to Obesity - 3 months ago
7	Kennedy Ferruggia, Assistant Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey pharmacyhealthcarejournalism	SABCS 2024: The Persistent Association Between Obesity and Breast Cancer Outcomes - 4 months ago Study Finds Obesity Remission Rates Are Lower Than Overweight Remission Rates in Children - over 1 year ago
8	The Conversation Science Alert Science news. Official account. Australia science news	Scientists Predict 80% of American Adults Will Be Overweight or Obese by 2050 - 4 months ago Does Obesity Protect Against Dementia, or Increase Risk? - 11 months ago
9	Andrew Joseph STAT News Reporter at STAT. Covers health, medicine in Europe. London, England health reportingmedicine	STAT+: Amgen drug leads to substantial weight loss in study, but questions remain about competitiveness - 5 months ago STAT+: A second Roche obesity drug shows promise in early studies - 9 months ago STAT+: Viking Therapeutics to move its oral obesity drug into Phase 2 study after early success - about 1 year ago STAT+: Obesity treatment from Boehringer Ingelheim, Zealand Pharma succeeds in study in liver condition MASH - about 1 year ago STAT+: What comes after Wegovy? The quest to eradicate obesity - over 1 year ago STAT+: Pfizer to halt development of its twice-daily oral obesity drug, following disappointing trial - over 1 year ago
10	Rebecca Pifer Healthcare Dive Reporter @healthcaredive. New York City, United States insurancedigital health	Biden administration proposes Medicare, Medicaid coverage of pricey weight loss drugs - 5 months ago Biden administration proposes Medicare, Medicaid coverage of pricey weight loss drugs - 5 months ago

Journalists covering obese